CRISPRMED24 Testimonial - Colette Rogers, Ph.D
By: WeDoCRISPR - Nov. 25, 2024
Colette Rogers PhD is a postdoctoral researcher at the University of Minnesota, working on the development of new gene-editing approaches to treat Fanconi anaemia. In this WeDoCRISPR video, she shares her thoughts on the inaugural CRISPR Medicine Conference which was held in Copenhagen in April 2024. Have a listen!
Tags
CLINICAL TRIALS
IND Enabling
Phase I
Phase II
Phase III
IND Enabling
Phase I
Phase II
Phase III
Transthyretin Amyloidosis with Polyneuropathy, ATTRv-PN, (NCT06672237)
Sponsors:
Intellia Therapeutics
Sponsors:
Intellia Therapeutics
IND Enabling
Phase I
Phase II
Phase III